In accordance with the Food and Drug Administration's change order for pharmaceutical manufacturing (import) items (Permission Review and Coordination Division-No. 2150, effective date 2009.10.6), the precautions for use of Levamide tablets and the efficacy and dosage of Pyrosin tablets have been changed.
 


For further details, please refer to the ‘Product Introduction’ section and attached documents.